If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.
It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.
Wiley InterScience | ||
![]() Ophthalmic and Physiological OpticsVolume 11 Issue 3, Pages 206 - 217 Published Online: 19 Dec 2007 Journal compilation © 2010 The College of Optometrists The Journal of the College of Optometrists
Abstract | References | Full Text: PDF (Size: 7909K) | Related Articles | Citation Tracking Tinted lenses and related therapies for learning disabilities – a review Copyright 1991 Butterworth-Heinemann for British College of Optometrists ABSTRACTResearch relating to the use of Irlen tinted lenses and coloured overlays for underachieves is reviewed Many of the studies were not published in refereed journals and were methodologically poor. The weaknesses of the Irlen argument arc discussed, including the absence of evidence to support the claims that these tints need to he uniquely prescribed and manufactured. Syntonics is another form of visual colour therapy that has been applied to those with a learning disability. Research on this is reviewed, and is also shown lo have procedural irregularities which preclude firm conclusions. Owing to the poor quality of much of this research the claims of the protagonists of these therapies cannot be proved or disproved. A proposed new therapy is normally preceded by a valid theoretical hypothesis: this has been lacking in the present topic. Recently, a feasible explanation has been proposed in terms of 'pattern glare' resulting from mild hypersensitivity to epileptogenic patterns. This, together with potential alternative theories, is discussed, In the conclusion of this review, advice is given for eye-care practitioners who may be consulted on these therapies. Received 12 February 1991, in revised form 5 April 1991 |